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ABSTRACT
Background: Histological examination of the liver remains the gold standard of assessing liver cirrhosis. 
However, this examination is an invasive method with many complications. This study aims to determine the 
relationship between degree of liver fibrosis with red cell distribution width (RDW)/platelet ratio which can then 
be used as non-invasive diagnostic method of liver fibrosis. 
Method: This was a retrospective study, the data of hematological profiles including hemoglobin, RDW, and 
platelet was taken from medical records of all chronic hepatitis B patients undergoing Fibroscan at Sanglah 
Hospital in January 2016 to February 2017. 
Results: Of 58 patients, 10 patients was excluded due to chronic kidney disease, malignancy and coincide 
with hepatitis C and HIV. The analysis using Kruskal-Wallis test, found a significant relationship between 
RDW/platelet ratio with degree of fibrosis in chronic hepatitis B (p < 0.05). Of the 48 patients, 23 patients with 
mild-moderate fibrosis (metavir F0-2) and 25 patients with severe fibrosis (metavir F3-4) were found. In ROC 
analysis, the AUC was 0.734, using cut off 0,065 RDW/platelet ratio predict severe fibrosis about 7% sensitivity, 
specificity 73.9%, positive prediction value 73.1%, and negative prediction value 70.8%. 
Conclusion: The RDW/platelet ratio can be used as a noninvasive diagnostic test of liver fibrosis in chronic 
hepatitis B patients.
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ABSTRAK
Latar belakang: Pemeriksaan histologi hati merupakan baku emas diagnosis sirosis hepatis. Akan tetapi 
pemeriksaan ini merupakan pemeriksaan yang invasif dan memiliki banyak komplikasi. Penelitian ini bertujuan 
untuk mengetahui adanya hubungan antara derajat fibrosis hati dengan rasio red cell distribution width (RDW)/
platelet yang selanjutnya dapat digunakan sebagai petanda fibrosis hari non-invasif. 
Metode: Penelitian ini merupakan penelitian retrospektif, data diambil dari rekam medis semua penderita 
hepatitis B kronik yang menjalani Fibroscan di RSUP Sanglah pada bulan Januari 2016 sampai Februari 2017. 
Hasil: Dari 58 pasien, dieksklusi pasien dengan penyakit ginjal kronik, keganasan, dan koinfeksi dengan 
hepatitis C maupun HIV, sehingga jumlah subyek yang diteliti sebanyak 48 pasien. Analisa hubungan 
menggunakan kruskal-wallis, didapatkan adanya hubungan yang signifikan antara RDW, platelet, RDW/platelet 
rasio dengan derajat fibrosis pada hepatitis B kronik. Dari 48 pasien, didapatkan 23 pasien dengan fibrosis 
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ringan-sedang (metavir F0-2) dan 25 pasien dengan sirosis (metavir F3-4). Pada analisa ROC didapatkan AUC 
73,4%, dan dengan menggunakan cut off 0,065 didapatkan sensitivitas 76%, spesifisitas 73,9%, nilai prediksi 
positif sebesar 73,1%, nilai prediksi negatif 70,8%. 
Simpulan: Disimpulkan bahwa rasio RDW/platelet dapat digunakan sebagai petanda non-invasif derajat 
fibrosis hati pada penderita hepatitis B kronik.
Kata kunci: fibroscan, rasio RDW/platelet, fibrosis hati, hepatitis B kronik.
INTRODUCTION
Chronic Hepatitis B infection is one of the main 
causes of liver fibrosis and cirrhosis, as well as other 
known causes such as hepatitis C virus, alcoholic 
liver disease, and non-alcoholic liver disease. These 
infections often show no symptoms until eventually 
the patient falls under conditions of liver cirrhosis 
with various complications such as; bleeding due 
to variceal rupture, hepatic encephalopathy, ascites, 
renal impairment, and so fort.1 In the world, more than 
600,000 people die each year due to hepatitis B, with 
the highest endemic rate was found in Asia, which 
is about 45% 1. The prevalence of chronic hepatitis 
B in Indonesia varies from moderate to high (2.5-
10%) with the most sub-genotype being HBV/B3.2 
In general, chronic hepatitis B results in 45% of HCC 
(Hepatocellular Carcinoma) cases and 30% of hepatic 
cirrhosis.1 Therefore examination of liver fibrosis is 
important for early detection of liver complications, 
reduces morbidity and mortality due to hepatitis B.
Until now, histological examination of the liver 
tissue remains the gold standard of liver fibrosis 
assessment. In addition, liver biopsy examination 
is also useful for diagnosing various pathologic 
abnormalities of the liver such as; autoimmune 
hepatitis, alcoholic liver disease, non-alcoholic 
liver disease, determine prognosis, and as a guide in 
determining therapy. However, this procedure is also 
associated with the incidence of many complications 
such as bleeding, pain, and infection. Bleeding after 
a biopsy procedure can be mild to severe and cause 
death. Mild hemorrhage is bleeding that results in 
pain, tachycardia, or decreased blood pressure, but 
does not require transfusions. This condition may 
occur in 1 per 500 biopsies. While severe hemorrhage 
is hemorrhage that require hospitalization and blood 
transfusion, is estimated to occur in 1 per 2,500-10,000 
biopsies. Other complications that rarely occur are 
pneumothorax, hematothorax, and hollow organ 
perforations.3
Non-invasive examination began to be widely 
developed to replace the role of liver biopsy in order 
to avoid the complications of it. Transient elastography 
(TE, Fibroscan) is one of non-invasive examination 
using an ultrasound probe to assess the degree of liver 
fibrosis through liver stiffness.4,5 Shear waves with 
low amplitude and frequency are transmitted from 
the probe and evaluated for speed. The more rigid the 
liver tissue the waves will be delivered faster.6 This 
procedure is easy, fast, and has a good performance 
(AUC > 0.9), but low sensitivity in conditions of 
obesity and ascites.4,6 WHO 2016 recommends TE as 
a non-invasive examination to assess liver fibrosis in 
areas with no limitation in cost and resources.7
Various laboratory examinations are also widely 
developed as a model prediction of liver fibrosis, such 
as aspartate aminotransferase to platelet ratio index 
(APRI), gamma-glutamyltranspeptidase to platelet 
ratio (GPR), and FIB-4.8 Some have been validated 
and even APRI scores have also been recommended 
as an early screening of chronic liver disease in areas 
with limited resources.7 The red-cell distribution width 
(RDW)/platelet ratio is also suspected to be associated 
with degree of liver fibrosis.9 RDW is a variability 
of red blood cells volume in the circulation, and is 
often used to assess anemia type. RDW is routinely 
reported on complete blood count tests. An increase 
of RDW is known to be associated with inflammatory 
conditions, particularly chronic inflammation.2 While 
chronic hepatitis B patients is known to have dynamic 
condition related to the inflammation and fibrosis of 
the liver. Several previous studies have suggested that 
the RDW/platelet ratio is associated with liver fibrosis 
in patients with chronic hepatitis B.9,10,11,12 Study in 
primary biliary cirrhosis patients, the RDW/platelet 
ratio can predict liver fibrosis with 46.7% sensitivity 
and 96.4% specificity.13 Another study also showed an 
increase in RDW was associated with the incidence of 
cardiovascular complications and increased mortality.14
METHOD
This is an analytic retrospective study. The data 
were taken from medical record and Fibroscan 
register of Sanglah Hospital Bali in January 2016 
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until February 2017. Inclusion criteria were all 
chronic hepatitis B infected patients aged >12 years 
with positive HBsAg test results for 6 months or 
more, who came to Sanglah Hospital Denpasar and 
performed Fibroscan examination. Exclusion criteria 
were patients with coinfection HIV and hepatitis C, 
liver malignancy, iron deficiency anemia, chronic 
renal disease, idiopathic thrombocytopenia purpura 
and dengue hemorrhagic fever.
In the subjects of the study conducted medical 
record tracking of routine laboratory blood tests, 
liver physiology, HBsAg, diagnosis, and Fibroscan 
examination. The RDW/platelet ratio is calculated using 
the formula = RDW (%)/Plt (109 L-1). RDW data was 
taken within 1 month period of Fibroscan examination. 
If the patient has more than 1 data, the closest data 
period to the time of Fibroscan examination was chosen 
to minimize the bias. Fibroscan examination results 
were classified according to metavir, and groupings 
were made into 2 groups; mild-moderate fibrosis 
(metavir F0-2) and severe fibrosis (metavir F3-4). 
Analysis of the relationship between the RDW /platelet 
ratio to Fibroscan was performed using Kruskal-wallis. 
If the results are significant, the data will continue to 
analyse using receiver operating characteristic (ROC) 
curve to determine the area under curve (AUC), cut-off 
point, sensitivity, specificity, positive predictive value 
(PPV), and negative predictive value (NPV).
RESULTS
Of the 58 patients with chronic Hepatitis B, 
Fibroscan examined, excluded patients with chronic 
kidney disease, malignancy, and co-infection with 
hepatitis C or HIV, so that the number of subjects 
studied was 48 patients. The subjects consisted of 33 
men and 15 women, aged 15-71 years with an average 
of 41 years. Fibroscan examination results obtained 23 
people with mild-moderate fibrosis (metavir F0-2) and 
25 people severe fibrosis (metavir F3-4). The median 
RDW value of the study subjects was 13,03 %. The 
median platelet count was 170,55/mm³. The ratio of 
RDW/platelet obtained a median value of 0,0698. 
Descriptive statistical data are presented in Table 1.
Analysis of the relationship between RDW/platelet 
ratio with degree of liver fibrosis using Kruskal-wallis 
test showed significant results (p = 0.006). In the analysis 
using the ROC curve obtained, AUC at 73.4%, and using 
a cut-off point of 0.065, the RDW/platelet ratio can predict 
the presence of severe fibrosis with a sensitivity of 76%, 
specificity 73.9%, PPV 73.1%, and NPV 70.8 %.
Table 1. Characteristics of the subjects
Median Minimum Maximum
Age (years) 41 15 71
Liver stiffness (kPa) 10,9 4,10 72
Score metavir 3 0 4
Platelet count (/mm3) 170,55 6,1 362,90
RDW (%) 13,03 11,22 24,92
RDW/platelet ratio 0,0698 0,04 4,09
Figure 1. ROC curve
Area Under the Curve
Test Result Variable(s):  rdw to platelet ratio 
Area Std. Errora Asymptotic Sig.b
Asymptotic 95% 
Confidence Interval
Lower 
Bound
Upper 
Bound
.734 .078 .006 .580 .887
a. Under the nonparametric assumption
b. Null hypothesis: true area = 0.5
 Figure 2. Area under the curve (AUC)
DISCUSSION
Chronic hepatitis B leads to fibrosis in the liver 
resulting from inflammatory processes and chronic 
liver injury. Severe liver fibrosis will result in decreased 
liver function and portal hypertension. However, this 
condition remains no symptoms until the patient is 
in a condition of decompensated state. Under these 
conditions, the majority of patients present with many 
complications such as variceal bleeding, spontaneous 
bacterial peritonitis, or hepatic encephalopathy.15 
Therefore, histological examination of the liver 
becomes important in relation to the determination of 
therapy and prognosis. In 2016, WHO recommends 
assessing the degree of fibrosis in chronic hepatitis 
B patients to determine anti-viral therapy.7 The 
recommendation to checks are APRI and TE. In 
addition, this examination is recommended to be done 
at the first time and repeated at least once a year to 
assess the disease progression and evaluation of the 
treatment. When APRI obtained a value greater than 
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2 or a TE result indicates metavir ≥ 2 correlates with 
a significant fibrosis condition in the liver.7
Recently, RDW has been mentioned to be associated 
with some chronic pathological conditions, also as a 
prognostic factor in some diseases. Increased RDW 
was found in chronic liver disease, chronic renal 
disease, systemic lupus erythematosus (LES), and acute 
myocardial infarction.11 In addition, RDW was found 
to be positively correlated with degree of cirrhosis 
based on Child-Pugh score and increased mortality 
of patients with coronary heart disease.14,16 The 
mechanisms that can explain the condition until now 
is still unclear. Some elevation of pro-inflammatory 
cytokines, such as TNF-α, IL-1β (Interleukin-1β), and 
IL-6 (Interleukin-6), was suspected to be the cause of 
decreased levels of erythropoietin.17 This condition 
results in release of the immature red blood cell into 
the circulation and make an increase of RDW.18
Chen et al in 2013 found a significant association 
between RDW and platelet levels to the degree of 
liver fibrosis, which then made a prediction model 
of RDW/platelet ratio. Based on the results of the 
analysis, this ratio is better than APRI with AUC 0.825 
in predicting significant fibrosis.10 In this study, there 
was a significant relationship between RDW/platelet 
ratio and degree of liver fibrosis. In our study ROC 
analysis, obtained AUC of 0.706, lower than previous 
studies by Chen et al. This may be due to the small 
number of samples in this study and the characteristics 
of the sample also differed between the studies. 
The limitations of this study include the study was 
conducted as a retrospective design, which is allowing 
for a large amount of data that could not be taken, and 
no direct interviews with patients. In addition, this 
study was not evaluated for HBV DNA and HBeAg 
in patients, and no liver biopsy was performed as a 
golden standard of liver fibrosis.
In general, this RDW/platelet ratio has moderate 
accuracy in predicting severe fibrosis, and still could not 
replace the role of TE and liver biopsy in the diagnosis 
of liver fibrosis. However, this ratio can be used as an 
initial screening for severe fibrosis in chronic hepatitis 
B patients, especially in areas with limited resources, 
in addition to being relatively cheaper than other non-
invasive methods such as APRI, FIB-4, and GPR.
CONCLUSION
There is a relationship between the ratio of RDW/
platelet to the degree of liver fibrosis in people with 
chronic hepatitis B. This RDW/platelet ratio can 
then serve as an alternative non-invasive method for 
predicting severe liver fibrosis in chronic hepatitis B 
patients, especially in areas with limited resources.
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